Creative Hybrid Chemistry For a Better Tomorrow
Text Size :
Site Search
About the Company
Investor Relations
Business & Products
R&D
Sustainability
Top Message
See more
Three Reports of Sumitomo Chemical
Investors' Meeting for the Business Strategy (Agro & Life Solutions, ICT & Mobility Solutions)
Investors' Meeting for FY2024 1st Half Financial Results, Management Priorities and Business Strategies
Establishment of RACTHERA, the Regenerative Medicine and Cell Therapy Business Joint Venture
Understanding the Sumitomo Chemical Story
IR News